Inhibition of HCN1 currents by norquetiapine, an active metabolite of the atypical anti-psychotic drug quetiapine

MLA

Amélie Jean Jacques, and Nazzareno D’Avanzo. “Inhibition of HCN1 Currents by Norquetiapine, an Active Metabolite of the Atypical Anti-Psychotic Drug Quetiapine.” Frontiers in Pharmacology, vol. 15, Oct. 2024. EBSCOhost, https://doi.org/10.3389/fphar.2024.1445509.

APA

Amélie Jean Jacques, & Nazzareno D’Avanzo. (2024). Inhibition of HCN1 currents by norquetiapine, an active metabolite of the atypical anti-psychotic drug quetiapine. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1445509

Chicago

Amélie Jean Jacques, and Nazzareno D’Avanzo. 2024. “Inhibition of HCN1 Currents by Norquetiapine, an Active Metabolite of the Atypical Anti-Psychotic Drug Quetiapine.” Frontiers in Pharmacology 15 (October). doi:10.3389/fphar.2024.1445509.